Form 4 for EW Edwards Lifesciences
Accepted 2025-05-05 00:00:00 ET · period of report 2025-05-03 · accession 0001225208-25-004769 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-05 | 2025-05-03+ | EW | Lippis Daniel J. | CVP, JAPAC | F - Tax | $75.65 | -472 | 22.6K | -2% | -$35.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-04 | F | D | 247 | $75.65 | 22,391.11 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-03 | F | D | 225 | $75.65 | 22,638.11 | D | — | — |